Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience.
Gemici A, Aydogdu I, Terzi H, Sencan M, Aslan A, Kaya AH, Dal MS, Akay MO, Dogu MH, Ayyildiz O, Sahin F, Cagliyan GA, Yilmaz M, Gokgoz Z, Bilen Y, Demir C, Sevindik OG, Korkmaz S, Eser B, Altuntas F; ThREG, Turkish hematology Research and Education Group. Gemici A, et al. Among authors: aydogdu i. Hematol Oncol. 2018 Feb;36(1):116-120. doi: 10.1002/hon.2460. Epub 2017 Jul 14. Hematol Oncol. 2018. PMID: 28707314
Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy.
Hacioglu S, Bilen Y, Eser A, Sivgin S, Gurkan E, Yildirim R, Aydogdu I, Dogu MH, Yilmaz M, Kayikci O, Tombak A, Kuku I, Celebi H, Akay MO, Esen R, Korkmaz S, Keskin A. Hacioglu S, et al. Among authors: aydogdu i. Hematol Oncol. 2015 Dec;33(4):192-8. doi: 10.1002/hon.2177. Epub 2014 Nov 13. Hematol Oncol. 2015. PMID: 25393847
Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study.
Erkurt MA, Berber I, Tekgündüz E, Dogu MH, Korkmaz S, Demir C, Yilmaz M, Akay OM, Pala C, Bilen Y, Kaya E, Sari I, Sencan M, Kuku I, Altuntaş F, Dal MS, Aydogdu I. Erkurt MA, et al. Among authors: aydogdu i. Transfus Apher Sci. 2016 Feb;54(1):80-4. doi: 10.1016/j.transci.2016.01.018. Epub 2016 Jan 12. Transfus Apher Sci. 2016. PMID: 26810141
Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG).
Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Tekgündüz E, et al. Among authors: aydogdu i. Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. Transfus Apher Sci. 2017. PMID: 29153305
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study.
Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. Tekgündüz E, et al. Among authors: aydogdu i. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20. Transfus Apher Sci. 2018. PMID: 29503132
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.
Soyer N, Ali R, Turgut M, Haznedaroğlu İC, Yılmaz F, Aydoğdu İ, Pir A, Karakuş V, Özgür G, Kiş C, Ceran F, İlhan G, Özkan M, Aslaner M, İnce İ, Yavaşoğlu İ, Gediz F, Sönmez M, Güvenç B, Özet G, Kaya E, Vural F, Şahin F, Töbü M, Durusoy R, Saydam G. Soyer N, et al. Among authors: aydogdu i. Turk J Med Sci. 2021 Jun 28;51(3):1033-1042. doi: 10.3906/sag-1812-70. Turk J Med Sci. 2021. PMID: 33315343 Free PMC article.
Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.
Karadag FK, Yenerel MN, Yılmaz M, Uskudar H, Ozkocaman V, Tuglular TF, Erdem F, Unal A, Ayyildiz O, Ozet G, Comert M, Kaya E, Ayer M, Salim O, Guvenc B, Ozdogu H, Mehtap Ö, Sonmez M, Guler N, Hacioglu S, Aydogdu İ, Bektas O, Toprak SK, Kaynar L, Yagci M, Aksu S, Tombak A, Karakus V, Yavasoglu İ, Onec B, Ozcan MA, Undar L, Ali R, Ilhan O, Saydam G, Sahin F. Karadag FK, et al. Among authors: aydogdu i. Am J Blood Res. 2021 Jun 15;11(3):279-285. eCollection 2021. Am J Blood Res. 2021. PMID: 34322292 Free PMC article.
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.
Tombak A, Pepedil Tanrıkulu F, Durusoy SS, Dinçyürek HD, Kaya E, Ümit EG, Yavaşoğlu İ, Mehtap Ö, Deveci B, Özcan MA, Terzi H, Okay M, Sayınalp N, Yılmaz M, Okan V, Kızıklı A, Özcan Ö, Çetin G, Demircioğlu S, Aydoğdu İ, Saydam G, Davulcu EA, İlhan G, Uçar MA, Özet G, Akpınar S, Turgut B, Berber İ, Kurtoğlu E, Sönmez M, Batur DS, Yıldırım R, Özkocamaz V, Güneş AK, Sahip B, Ertop Ş, Akay OM, Baştürk A, Doğu MH, Akdeniz A, Ünal A, Seyhanlı A, Gürkan E, Çekdemir D, Ferhanoğlu B. Tombak A, et al. Among authors: aydogdu i. Turk J Haematol. 2021 Dec 7;38(4):273-285. doi: 10.4274/tjh.galenos.2021.2021.0007. Epub 2021 Aug 27. Turk J Haematol. 2021. PMID: 34448556 Free PMC article.
191 results